IRIS
DI SARNO, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 639
EU - Europa 267
AS - Asia 200
AF - Africa 6
SA - Sud America 4
Totale 1.116
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 632
CN - Cina 111
SG - Singapore 80
NL - Olanda 60
IT - Italia 42
DE - Germania 37
IE - Irlanda 36
FI - Finlandia 35
SE - Svezia 30
UA - Ucraina 14
GB - Regno Unito 8
CA - Canada 6
CI - Costa d'Avorio 6
IN - India 4
TR - Turchia 3
AR - Argentina 2
CZ - Repubblica Ceca 2
FR - Francia 2
AT - Austria 1
CL - Cile 1
EC - Ecuador 1
HK - Hong Kong 1
MX - Messico 1
MY - Malesia 1
Totale 1.116
Salva come PNG Salva come JPEG
Città #
Chandler 178
Amsterdam 59
Singapore 59
Millbury 56
Jacksonville 42
Nanjing 42
Princeton 35
Wilmington 24
Ashburn 17
Santa Clara 15
Nanchang 12
Ann Arbor 11
Beijing 11
Naples 11
Norwalk 11
Shenyang 7
Ottawa 6
Kunming 5
Seattle 5
Tianjin 5
Jiaxing 4
Changsha 3
Des Moines 3
Hebei 3
Jinan 3
Milan 3
Ningbo 3
Pune 3
San Sebastiano al Vesuvio 3
Torino 3
Bari 2
Boardman 2
Boston 2
Brno 2
Dearborn 2
Guangzhou 2
Helsinki 2
Kronberg 2
Munich 2
Napoli 2
New York 2
Rome 2
Tappahannock 2
Zhengzhou 2
Agropoli 1
Castellammare di Stabia 1
Changchun 1
Chicago 1
Ciudad Obregón 1
Cordoba 1
Dallas 1
Duncan 1
Grammichele 1
Harbin 1
Hong Kong 1
Indiana 1
Kuala Lumpur 1
Lafayette 1
Leawood 1
Los Angeles 1
Moreno 1
Mumbai 1
Paris 1
Quito 1
Redmond 1
Redwood City 1
San Francisco 1
San Jose 1
San Prisco 1
Shijiazhuang 1
Simi Valley 1
Taizhou 1
The Dalles 1
Vienna 1
Totale 700
Salva come PNG Salva come JPEG
Nome #
Hepatic arterial embolization in patients with neuroendocrine tumors. 60
Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma 53
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine 51
The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males. 46
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 43
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 43
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 40
Corticotropin-releasing hormone administration increases alpha-melanocyte-stimulating hormone levels in the inferior petrosal sinuses in a subset of patients with Cushing's disease 39
An evaluation of patients with hyperprolactinemia: have dynamic tests had their day? 39
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors 39
Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly 38
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients 38
Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases 38
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 38
Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males 36
Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas 33
Effect of different dopaminergic agents in the treatment of acromegaly 33
Corticotropin-releasing hormone test: improvement of the diagnostic accuracy of simultaneous and bilateral inferior petrosal sinus sampling in patients with Cushing syndrome 31
CV 205-502 treatment in therapy-resistant acromegalic patients 31
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas. 31
Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline 31
Evolution of an aggressive prolactinoma into a growth hormone secreting pituitarytumor coincident with GNAS gene mutation. 31
Hyperprolactinemia in men: clinical and biochemical features and response to treatment 29
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas 27
Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage 26
Power Doppler improves the diagnostic accuracy of color Doppler ultrasonography in cold thyroid nodules: follow-up results 25
Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly 25
Prediction of efficacy of octreotide therapy in patients with acromegaly 24
Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's disease 23
Usefulness of CV 205-502 in a case of allergy to ergot-derived drugs. 22
Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment 21
Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up 19
Simultaneous and bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's syndrome: comparison of multihormonal assay, baseline multiple sampling and ACTH-releasing hormone test 18
Prostatic hyperplasia: an unknown feature of acromegaly 16
Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia 16
Totale 1.153
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.337
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202048 0 0 0 0 0 2 0 0 1 2 13 30
2020/202155 1 5 5 3 4 17 3 0 5 3 5 4
2021/2022226 1 0 0 1 5 22 2 6 38 26 40 85
2022/2023378 37 37 16 33 46 39 1 34 52 64 11 8
2023/2024133 9 32 18 7 2 8 6 13 0 1 19 18
2024/2025101 42 29 1 10 19 0 0 0 0 0 0 0
Totale 1.153